The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit

Burns

Volumn 31, Issue 7, 2005, Pages 870-873

  Ozkurt, Zulal ^a   Ertek, Mustafa ^a   Erol, Serpil ^a   Altoparlak, Ulku ^a   Akcay, M Nuran ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Burn; Imipenem resistance; P. aeruginosa; Risk factors

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBAPENEM; CIPROFLOXACIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BODY SURFACE; BURN; CLINICAL FEATURE; COMPARATIVE STUDY; CONTAMINATION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; TIME SERIES ANALYSIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BURN UNITS; BURNS; CASE-CONTROL STUDIES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; IMIPENEM; LENGTH OF STAY; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 25844462305     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2005.04.015     Document Type: Article

References (28)

1. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001;47:247-50.
2. H. Goosssens Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group Clin Microbiol Infect 9 2003 980 983
3. L.M. Deshpande, T.R. Fritsche, and R.N. Jones Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program Diagn Microbiol Infect Dis 49 4 2004 231 236
4. A.D. Harris, D. Smith, J.A. Johnson, D.D. Bradham, and M.C. Roghmann Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients Clin Infect Dis 34 3 2002 340 345
5. N. Troillet, M.H. Samore, and Y. Carmeli Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns Clin Infect Dis 25 5 1997 1094 1098
6. Z. Gulay, T. Atay, and S.G. Amyes Clonal spread of imipenem-resistant Pseudomonas aeruginosa in the intensive care unit of a Turkish hospital J Chemother 13 5 2001 546 554
7. B. Cao, H. Whang, H. Sun, Y. Zhu, and M. Chen Risk factors and clinical outcomes of nosocomial multi-drug-resistant Pseudomonas aeruginosa infections J Hosp Infect 57 2004 112 118
8. A.P. Zavascki, R.P. Cruz, and L.Z. Goldani Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients J Hosp Infect 59 2 2005 96 101
9. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003;31(8):481-98.
10. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32(8):470-85.
11. S.G. Santucci, S. Gobara, C.R. Santos, C. Fontana, and A.S. Levin Infections in a burn intensive care unit: experience of seven years J Hosp Infect 53 1 2003 6 13
12. W. Song, K.M. Lee, H.J. Kang, D.H. Shin, and D.K. Kim Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea Burns 27 2 2001 136 139
13. M.F. Geyik, M. Aldemir, S. Hosoglu, and H.I. Tacyildiz Epidemiology of burn unit infections in children Am J Infect Control 31 6 2003 342 346
14. B.A. Pruitt Jr., A.T. McManus, S.H. Kim, and C.W. Goodwin Burn wound infections: current status World J Surg 22 2 1998 135 145
15. S. Erol, U. Altoparlak, M.N. Akcay, F. Celebi, and M. Parlak Changes of microbial flora and wound colonization in burned patients Burns 30 4 2004 357 361
16. U. Altoparlak, S. Erol, M.N. Akcay, F. Celebi, and A. Kadanali The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients Burns 30 7 2004 660 664
17. O. Oncul, F. Yuksel, H. Altunay, C. Acikel, B. Celikoz, and S. Cavuslu The evaluation of nosocomial infection during 1-year-period in the burn unit of a training hospital in Istanbul, Turkey Burns 28 8 2002 738 744
18. R. Zhang, Y. Jin, and C. Han The isolation of Pseudomonas aeruginosa from burn wound and the analysis of its antibiotic resistant spectrum Zhonghua Shao Shang Za Zhi 18 5 2002 285 287 [Abstract]
19. C.L. Lund, and N.C. Browder The estimation of areas of burns Surg Gynecol Obstet 79 1994 352
20. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. 6th ed. Approved Standard. NCCLS Document M2-A6, vol. 17, No. 1, Pennsylvania.
21. C. Lagatolla, E.A. Tonin, C. Monti-Bragadin, L. Dolzani, F. Gombac, and C. Bearzi Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-beta-lactamase determinants in European hospital Emerg Infect Dis 10 3 2004 535 538
22. M.J. Lynch, G.L. Drusano, and H.L. Mobley Emergence of resistance to imipenem in Pseudomonas aeruginosa Antimicrob Agents Chemother 31 12 1987 1892 1896
23. U. Vurma-Rap, F.H. Kayser, K. Hadorn, and F. Wiederkehr Mechanism of imipenem resistance acquired by three Pseudomonas aeruginosa strains during imipenem therapy Eur J Clin Microbiol Infect Dis 9 8 1990 580 587
24. V Krcmery Jr, J. Trup, A. Kunova, S. Spanik, L. Drgona, and E. Oravcova Imipenem-resistant P. aeruginosa bacteremia in cancer patients: risk factors, clinical features and outcome Int J Clin Pharmacol Res 16 2-3 1996 43 49
25. E.M. Mokaddads, and S.C. Sanyal Resistance patterns of Pseudomonas aeruginosa to carbapenem and piperacillin/tazobactam J Chemother 11 2 1999 93 96
26. Herruzo Cabrera R, Garcia Torres V, Martinez Ratero S, Denia Lafuente R, Rey Calero J. Risk factors for local infection in burns. Multivariate study. Med Clin (Barc) 1996;106(3):91-4 [Abstract].
27. T.H. Wong, B.H. Tan, M.L. Ling, and C. Song Multi-resistant Acinetobacter baumannii on a burns unit - clinical risk factors and prognosis Burns 28 4 2002 349 357
28. M.B. Edmond, and R.P. Wenzel Isolation G.L. Mandell J.E. Bennett R. Dolin Principles and practice of infectious diseases 5th ed. 2000 Churchill Livingstone New York 2991 3004